Inventor · disambiguated record
Gangadhara Ganapati
Also filed as: GANAPATI GANGADHARA
10 granted patents·22 pending applications·98 citations·filing 2010–2025
90Inventor score
Files withADAMAS PHARMACEUTICALS INC14MITOPOWER LLC8ADAMAS PHARMA LLC6MITOPOWER INC2ADARMAS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
32 records- 0196US9877933B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 30, 2018·15 cites·31 claims
- 0296US9867793B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 16, 2018·15 cites·43 claims
- 0396US9867791B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 16, 2018·17 cites·56 claims
- 0496US9867792B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 16, 2018·15 cites·19 claims
- 0596US8741343B2Method of administering amantadine prior to a sleep periodWENT GREGORY T·Filed 2010·Granted Jun 3, 2014·29 cites·29 claims
- 0688US11197835B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2019·Granted Dec 14, 2021·2 cites·16 claims
- 0782US11286274B2Nicotinamide riboside derivatives and their usesMITOPOWER LLC·Filed 2018·Granted Mar 29, 2022·4 cites·7 claims
- 0877US11833167B2Nicotinyl riboside compounds and their usesMITOPOWER LLC·Filed 2019·Granted Dec 5, 2023·1 cites·7 claims
- 0972US2018263928A1Amantadine compositions and methods of useADAMAS PHARMA LLC·Filed 2018·Application pending·0 cites
- 1070US12178827B2Nicotinyl riboside compounds and their usesMITOPOWER LLC·Filed 2023·Granted Dec 31, 2024·0 cites·8 claims
- 1170US2015045446A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1270US2015051292A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1370US2015045438A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1470US2015045439A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1570US2015045448A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1670US2015045447A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1770US2015057355A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1869US2014242163A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1966US2025367229A1Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives ThereofMITOPOWER LLC·Filed 2025·Application pending·0 cites
- 2065US2024382512A1Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives ThereofMITOPOWER LLC·Filed 2024·Application pending·0 cites
- 2164US2016263053A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2264US2016256414A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2364US2016151307A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2464US2016263057A1Amantadine compositions and methods of useADARMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2564US2016263056A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2664US2016263054A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2764US2016263055A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2862US12168673B2Prodrugs derived from nicotinic acid and riboseMITOPOWER INC·Filed 2023·Granted Dec 17, 2024·0 cites·24 claims
- 2962US2025129112A1Novel Prodrugs Derived from Nicotinic Acid and RiboseMITOPOWER INC·Filed 2024·Application pending·0 cites
- 3060US2023255995A1Nicotinyl Riboside Compounds and Their UsesMITOPOWER LLC·Filed 2023·Application pending·0 cites
- 3159US2023014055A1Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives ThereofMITOPOWER LLC·Filed 2022·Application pending·0 cites
- 3248US2020397807A1Nicotinyl riboside compounds and their usesMITOPOWER LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gangadhara Ganapati files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →